China is excelling in health tech. That’s good news for the world
Rest of World Viola Zhou
China is expanding digital healthcare—using apps, telemedicine, and AI doctor chat—while also increasing drug research and licensing as Western firms buy rights to Chinese-developed medicines. The article says China’s share of global drug out-licensing deals could reach 60% this year. As a result, more drug and health-tech capabilities from China are entering global markets, while debates over safety, trade restrictions, and what the West will accept (including AI medical avatars) intensify.
Why it matters
Ruby Wang, a physician and biotech consultant in the U.K., on her upcoming book on the emergence of China as a global health superpower.
Related stories
China on pace for 'new record-high trade surplus' this year as exports jump 25%—a part of its efforts to become a 'major player in AI infrastructure'
Fortune ·
48